Exciting research projects and novel therapies
Infections continue to threaten human health as pathogenic organisms outsmart available therapies with remarkable genetic versatility. Fortunately, microbial versatility is matched by the flexibility of the host immune system, which provides a rich source of novel therapeutic concepts.
Our therapeutic strategy is to find and develop substances that strengthen the immune system.
Rather than drugs killing the bacteria directly the patient’s immune system is empowered to deal with the bacteria.
Our goal is to provide a different molecular framework for the treatment of bacterial infections; much needed to combat antibiotic resistance.
Wullt, B. et al. European Urology Open Science, 31, 49-58, doi: 10.1016/j.euros.2021.07.003 (2021).
Ambite, I. et al. Letter to the Editor, The Journal of Clinical Investigation 131(18):e153234 doi: 10.1172/JCI153234 (2021).
Ambite, I. et al. Review Article, Nature Reviews Urology 18, 468–486, doi:10.1038/s41585-021-00477-x (2021).
PDF: NRU 2021
Ambite, I. et al. The Journal of Clinical Investigation 131(4), e140333, doi:10.1172/JCI140333 (2021).
PDF: JCI 2021
Butler, D.S.C. et al. Scientific Reports 8, 11015, doi:10.1038/s41598-018-28634-0 (2018).
PDF: Sci reports 2018
IRF7 inhibition prevents destructive innate immunity—A target for nonantibiotic therapy of bacterial infections
Puthia, M. et al. Science Translational Medicine 8(336), 336ra59, doi: 10.1126/scitranslmed.aaf1156 (2016).
PDF: Sci Trans Med 2016
Ambite, I. et al. PLoS Pathogens 12(10), e1005848, doi:10.1371/journal.ppat.1005848 (2016).
PDF: Plos Pathogens 2016
Lutay, N. et al. The Journal of Clinical Investigation 123(6), 2366-79, doi: 10.1172/JCI6645 (2013).
PDF: JCI 2013